UT Biotic


PACran that provides a unique class of proanthocyanidins clinically shown to resist adhesion of unwelcome bacteria in the urinary tract. It joins 25 billion probiotics from 7 strains known to be beneficial for urogenital health as identified in the scientific literature.*

  • Benefits - Urinary Tract
  • Healthy - Urogenital Bacteria
  • Helps Maintain - Good Probiotic Bacteria
  • Normal - Immunity
  • Promotes - prevention of recurrent UTIs
  • Supports - decrease attachment of E. coli

As a dietary supplement, take one (1) capsule daily approximately one hour after eating. Do this daily to help maintain healthy urogenital bacteria.

Probiotics play a major role in the maintenance and prevention of the colonization of pathogenic bacteria. Lactobacillus acidophilus and L. paracasei in particular have been shown to inhibit, by exclusion and competition, the adhesion of Staphylococcus aureus, Group B streptococci, and Gardnerella vaginalis to the vaginal tissues. 

Female Specific Science:

These Lactobacillus strains and others (L. rhamnosus, L. fermentum) have been identified as anti-infective agents in the vagina. The benefits seem to derive from hydrogen peroxide (H2O2), lactic acid, and natural antibiotics (bacteriocins) produced by the probiotic bacteria. It should be noted, however that none was able to decrease the attachment of E. coli.*

Good probiotic bacteria dominate the urinary and vaginal (urogenital) flora of healthy women.  Specific probiotics benefit healthy urogenital systems. They resist attachment of undesirable bacteria to the vaginal lining, and/or produce hydrogen peroxide, lactic acid and other natural substances, which retard growth of potentially harmful bacteria.*

  1. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells, Zárate G, Nader-Macias ME, Centro de Referencia para Lactobacilos (CERELA)-CONICET, San Miguel de Tucuman, Argentina. Lett Appl Microbiol.2006 Aug;43(2):174-80

  2. Probiotics for the treatment of women with bacterial vaginosis., Falagas ME, Betsi GI, Athanasiou S., Alfa Institute of Biomedical Sciences, Marousi, Greece., Clin Microbiol Infect.2007 Jul;13(7):657-64

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Related products